The LEAD conference hosted by Bio Ascend will empower women in the fields of Oncology and Hematology to overcome barriers.
The LEAD conference hosted by Bio Ascend will empower women in the fields of Oncology and Hematology to overcome barriers.
September 12, 2019
Santa Monica, CA– Women leaders in the fields of hematology and oncology will gather for two days, October 4-5, at the Loews Santa Monica Beach Hotel in Santa Monica, Calif., for essential clinical updates, career development workshops, and professional networking opportunities. Leadership Empowerment and Development: Enriching Experiences for Women in Hematology and Oncology (LEAD) Conference, hosted by Bio Ascend, will focus on addressing challenges women face in the oncology and hematology fields, and identifying actionable strategies for women to advance into leadership roles.
Clinical presentations will explore topics such as Challenges with Biomarkers in Cancer Drug Development, CAR T Cell Therapy, Treatment Evolution in Triple Negative Breast Cancer, and Addressing Unmet Clinical Needs in Advanced Ovarian Cancer. The conference will also feature interactive workshops on Building Resiliency to Prevent Burnout, Building Your Brand, and Leaning Into Leadership Opportunities. Attendees will also have the opportunity to receive one-on-one mentoring from conference faculty.
“During our usual academic interactions, we often don’t have time or expertise to discuss the critical issues that women face in oncology,” said Dr. Julie Vose, Co-Chair of the LEAD Conference. “This is a unique opportunity to interact with women in oncology from a variety of backgrounds and experiences.”
The LEAD conference is co-chaired by Julie Brahmer, MD, MSc; Nina Shah, MD; and Julie Vose, MD, MBA. The three co-chairs will also be featured keynote speakers at the conference, joining presenters from MD Anderson, Vanderbilt Ingram Cancer Center, University of Chicago, United States Food and Drug Administration, Bristol-Myers Squibb, City of Hope, Texas Oncology, University of Arizona Cancer Center, and others.
Dr. Julie Brahmer is a board-certified medical oncology physician and a Professor of Oncology in the Department of Oncology, Upper Aerodigestive Cancer, and Director of the Thoracic Oncology Program at Johns Hopkins University Medicine in Baltimore, Maryland. She also serves as the Co-Director of the Upper Aerodigestive Department at the Bloomberg–Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University, and in several other leadership roles.
Dr. Nina Shah is a board-certified hematology and medical oncology physician and an Associate Professor in the Department of Medicine at the University of California San Francisco in San Francisco, California. Dr. Shah also serves as Contributing Editor of the Journal of Patient-Centered Research & Reviews and is an editorial reviewer for at least seven peer-reviewed journals.
Dr. Julie Vose is a board-certified hematology and medical oncology physician on faculty at the University of Nebraska Medical Center in Omaha, Nebraska. Dr. Vose is the Neumann M. and Mildred E. Harris Professor and Chief of the Division of Hematology/Oncology at the University of Nebraska Medical Center and is a leader in Hodgkin and non-Hodgkin lymphoma and previous American Society of Clinical Oncology (ASCO) president.
All professionals who work in hematology or oncology are invited to attend the LEAD Conference, including community and academic physicians, advanced practitioners, nurses, and any other healthcare providers who treat patients with cancer. University of Nebraska Medical Center, Center for Continuing Education and College of Nursing, Continuing Nursing Education Office, will certify the LEAD conference for continuing education credits for physicians and contact hours for nurses.
Learn more and register for the LEAD Conference at www.LeadOncology.com.
About Bio Ascend: Bio Ascend is an independent medical education company committed to supporting health care providers in their efforts to translate innovative science into clinical practice.
The Bio Ascend team has deep oncology and hematology expertise with a proven ability to distill complex scientific ideas into their essential components as well as extensive experience in planning, executing, and assessing meaningful education for clinicians.
About University of Nebraska Medical Center: UNMC, a comprehensive cancer center, is currently conducting 125 clinical trials for patients with cancer. UNMC/CCE certifies approximately 800 activities for continuing medical education (CME) credit annually resulting in more than 50,000 interactions per year with healthcare professionals. UNMC CON CNE provides an average of over 750 activities annually, resulting in an average of over 15,000 interactions per year with nurses at all practice levels. About 10 percent of the focus is on oncology.
